The Role of Prolactin in Assessing Luteal Phase Infertility
DOI:
https://doi.org/10.54112/bcsrj.v6i6.1934Keywords:
Hyperprolactinemia; Luteal phase defect; Infertility; Endometrial histology; Progesterone; EstradiolAbstract
Luteal phase defect (LPD) is implicated in a substantial proportion of infertility cases, yet the role of circulating prolactin in luteal competence remains controversial. Although prolactin supports corpus luteum function in vitro, its utility as a clinical marker for luteal adequacy in women with regular cycles and no galactorrhea is unclear. Objective: To determine the prevalence of midluteal hyperprolactinemia among infertile women and to assess its association with luteal phase parameters, including cycle length, progesterone and estradiol levels, and endometrial histology. Methods: In this cross-sectional study, 130 infertile women aged 20–40 years with regular ovulatory cycles and no clinical hyperprolactinemia underwent basal body temperature monitoring, midluteal hormone assays, and endometrial biopsy. Plasma prolactin, progesterone, and estradiol were quantified by radioimmunoassay between four and ten days post-ovulation. Endometrial samples obtained on cycle days 21–24 were histologically staged using Noyes and Dallenbach‐Hellweg criteria; repeat biopsy was performed if initial results suggested LPD. Hyperprolactinemia was defined as prolactin above the laboratory reference range. Results: Fifteen women (11.5%) were hyperprolactinemic and 115 (88.5%) normoprolactinemic. LPD occurred in 1/15 (6.7%) hyperprolactinemic versus 20/115 (17.4%) normoprolactinemic women (p=0.13). Mean luteal phase length (13.0±1.4 vs 13.1±1.6 days), midluteal progesterone (13.3±4.8 vs 14.4±5.1 ng/mL), and estradiol (233±102 vs 227±99 pg/mL) did not differ significantly between groups. Four hyperprolactinemic women conceived spontaneously or with minimal support; others had additional infertility factors or remain under evaluation. Conclusions: Midluteal hyperprolactinemia is neither common nor predictive of luteal dysfunction in infertile women with regular cycles and no galactorrhea. A comprehensive assessment, incorporating histologic dating and steroid profiling, remains essential for accurate diagnosis of LPD and tailored infertility management
Downloads
References
Schooley JP, Riddell J. The morphological basis of pituitary function in pigeons. Am J Anat. 1938; 62:313? https://doi.org/10.1002/aja.1000620302
McNatty KP, Hunter WM, McNeilly AS, Sawers RS. Changes in the concentration of pituitary and steroid hormones in the follicular fluid of human Graafian follicles throughout the menstrual cycle. J Endocrinol. 1975; 64:555. https://doi.org/10.1677/joe.0.0640555
Vara JF, Carretero MV, Gerónimo H, Ballmer-Hofer K, and Martín-Pérez J. Stimulation of c-Src by prolactin is independent of Jak2. Biochem J. 2000; 345(Pt 1):17–24. https://doi.org/10.1042/0264-6021:3450017
McNatty KP, McNeilly AS, Sawers RS. Prolactin and progesterone secretion by human granulosa cells in vitro. In: Crosignani PG, Robyn C, editors. Prolactin and Human Reproduction. New York: Academic Press; 1977. p. 109–117.
Chang RJ. Normal and abnormal prolactin metabolism. Clin Obstet Gynecol. 1978; 21:125.
Tsai-Morris CH, Dufau ML. Prolactin receptor (PRLR). In: Atlas Genet Cytogenet Oncol Haematol (Internet). Salamanca (Spain): Institute for Biomedical Research of Salamanca; 2011 (cited 2023 Dec 26). Available from: http://atlasgeneticsoncology.org/gene/42891/
Poindexter AN, Buttram VC Jr, Besch PK, Smith RG. Prolactin receptors in the ovary. Fertil Steril. 1979; 31:273–?. https://doi.org/10.1016/S0015-0282(16)44004-8
Ross GT, Hillier SG. Luteal maturation and luteal phase defect. Clin Obstet Gynaecol. 1978; 5:391.
Torner L. Actions of prolactin in the brain: from physiological adaptations to stress and neurogenesis to psychopathology. Front Endocrinol (Lausanne). 2016; 7:25. https://doi.org/10.3389/fendo.2016.00025
Tambascia M, Bahamondes L, Pinotti J, Collier AM, Dachs IN, Faundes A. Sustained hyperprolactinemia in a normally menstruating woman with apparently normal ovarian function. Fertil Steril. 1980; 34(3):282–284. https://doi.org/10.1016/S0015-0282(16)44964-2
Saunders DM, Hunter JC, Haase HR, Wilson GR. Treatment of luteal phase inadequacy with bromocriptine. Obstet Gynecol. 1979; 53:287.
Annos T, Thompson IE, Taymor ML. Luteal phase deficiency and infertility: difficulties encountered in diagnosis and treatment. Obstet Gynecol. 1979; 55:705.
Balasch J, Vanrell JA, Marquez M, Burzaco I, Gonzalez-Merlo J. Dydrogesterone versus vaginal progesterone in the treatment of the endometrial luteal phase deficiency. Fertil Steril. 1982;37(6):751https://doi.org/10.1016/S0015-0282(16)46333-8
Dallenbach-Hellweg G. Histopathology of the Endometrium. 2nd ed. Berlin: Springer-Verlag; 1975. p. 83.
Abraham GE, Swerdloff R, Tulchinsky D, Odell WD. Radioimmunoassay of plasma progesterone. J Clin Endocrinol Metab. 1971; 32(5):619–624. https://doi.org/10.1210/jcem-32-5-619
Abraham GE, Manlimos FS, Garza R. Radioimmunoassay of steroids. In: Abraham GE, editor. Handbook of Radioimmunoassay. New York: Marcel Dekker, 1977. p. 591.
Reuter AM, Kennes F, Gevaert Y, Franchimont P. Homologous radioimmunoassay for human prolactin. Int J Nucl Med Biol. 1976; 3(1):21–?. https://doi.org/10.1016/0047-0740(76)90053-1
Jones GS. The luteal phase defect. Fertil Steril. 1976; 27(4):351–356. https://doi.org/10.1016/S0015-0282(16)41769-3
Wentz AC. Manual of Gynecology. 2nd ed. Philadelphia: WB Saunders; 1976. p. 1–20.
Wenner R. Les antiprolactines. Actual Gynecol (Paris). 1975; 6:91. DOI not available.
Quigley HM, Haney AF. Evaluation of hyperprolactinemia: clinical profiles. Clin Obstet Gynecol. 1980; 23(2):337–348. https://doi.org/10.1097/00003081-198006000-00006
Archer DF. Physiology of prolactin. Clin Obstet Gynecol. 1980;23(2):325–335. https://doi.org/10.1097/00003081-198006000-00005
Schwärzler P, Untergasser G, Hermann M, Dirnhofer S, Abendstein B, Berger P. Prolactin gene expression and prolactin protein in premenopausal and postmenopausal human ovaries. Fertil Steril. 1997; 68(4):696–701. https://doi.org/10.1016/S0015-0282(97)00320-8
McNamara AV, Awais R, Momiji H, Dunham L, Featherstone K, Harper CV, et al. The transcription factor Pit-1 influences transcriptional timing in the dual-promoter human prolactin gene. Endocrinology. 2021;162(4):bqaa249. https://doi.org/10.1210/endocr/bqaa249.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Sindhu Channa, Razwan Ashraf
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
